Advances in Continuous Manufacturing for Small Molecule
Advances in Continuous Manufacturing for Small Molecule While continuous processes started with a few continuous steps, the maximal value of continuous manufacturing will be gained from increased integration. Several recent processes demonstrate this value. This session will focus on actual industrial processes, emphasizing the technical and business advantages of integration. Advances in the integration of unit operations, independently for API and drug product as well as the end-to-end integration of the two will be discussed over the course of the session.
Full Integration of Continuous Manufacturing
Sal Mascia, PhD, President and CEO
Mighty Machines; Integrating Design of Chemical Processes and Flow Reactor Systems
Matthew M. Bio, PhD, President and CEO
Enabling End to End Continuous Manufacturing: FDA Perspective
Sharmista Chatterjee, PhD, Division Director